Showing results (41-50 of 128) with videos related to

Sort By:
Pageof 13
European Journal of Internal Medicine|April 21, 2020
Serial investigation of Angiotensin-Converting Enzyme in sarcoidosis patients treated with Angiotensin-Converting Enzyme InhibitorMiriana d'Alessandro, Laura Bergantini, Anna Perrone, et al.
International Journal of Molecular Sciences|September 2, 2020
Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic ReviewPaolo Cameli, Elena Bargagli, Laura Bergantini, et al.
Immunologic Research|October 22, 2020
Utility of serological biomarker' panels for diagnostic accuracy of interstitial lung diseasesLaura Bergantini, Miriana d'Alessandro, Lucia Vietri, et al.
Clinical and Experimental Immunology|June 9, 2021
Adaptive immune system in pulmonary sarcoidosis-Comparison of peripheral and alveolar biomarkersMiriana d'Alessandro, Laura Bergantini, Paolo Cameli, et al.
Minerva Medica|November 23, 2019
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosisPaolo Cameli, Laura Bergantini, Miriana D'alessandro, et al.
European Journal of Clinical Investigation|April 21, 2020
Serum KL-6 levels in pulmonary Langerhans' cell histiocytosisMiriana d'Alessandro, Laura Bergantini, Paolo Cameli, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|July 28, 2021
Clinical phenotyping in sarcoidosis managementGiuseppe Domenico Rana, Miriana d'Alessandro, Luigi Rizzi, et al.
Biomedicines|August 26, 2022
The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World StudyPaolo Cameli, Valerio Alonzi, Miriana d'Alessandro, et al.
Tissue & Cell|August 13, 2024
Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung diseaseMiriana d'Alessandro, Edoardo Conticini, Laura Bergantini, et al.
Scientific Reports|June 12, 2020
Idiopathic Pulmonary Fibrosis Serum proteomic analysis before and after nintedanib therapyClaudia Landi, Laura Bergantini, Paolo Cameli, et al.
Pageof 13